User Tools

Site Tools


endocrine:start

This is an old revision of the document!


Endocrine Pharmacology

Endocrine pharmacology is organized by hormonal organ systems.

Each section links to physiology, pathophysiology, drug classes, and therapeutic strategy.


Diabetes & Glucose Regulation

1. Hypoglycemics (Increase Insulin Effect)

These agents increase insulin levels and carry hypoglycemia risk. Insulin Therapy

Rapid-Acting (Prandial)

Short-Acting

Intermediate-Acting

  • NPH (Humulin N®, Novolin N®)

Long-Acting (Basal)

Ultra-Long Acting

Sulfonylureas

Meglitinides

2. Anti-Hyperglycemics (Low Hypoglycemia Risk)

These agents improve glycemia without directly increasing insulin secretion.

Biguanides

Thiazolidinediones (TZDs)

GLP-1 Receptor Agonists

Dual GLP-1/GIP Incretin Agonists

Triple Incretin Agonists

SGLT2 Inhibitors

Thyroid

Thyroid Hormone Replacement

Antithyroid Drugs

Iodine Therapy

Symptom Control in Hyperthyroidism

Adrenal

Glucocorticoids

  • Prednisone (Deltasone®)
  • Hydrocortisone (Cortef®)
  • Dexamethasone (Decadron®)

Mineralocorticoids

  • Fludrocortisone (Florinef®)

Steroid Synthesis Inhibitors

  • Ketoconazole
  • Metyrapone

Pituitary

Dopamine Agonists

  • Cabergoline (Dostinex®)
  • Bromocriptine (Parlodel®)

Somatostatin Analogs

  • Octreotide (Sandostatin®)
  • Lanreotide (Somatuline®)

Growth Hormone Therapies

Vasopressin & Analogues

  • Desmopressin (DDAVP®)

Reproductive Endocrinology

Estrogen Therapy

Progesterone Therapy

Hormonal Contraception

Selective Estrogen Receptor Modulators (SERMs)

  • Tamoxifen (Nolvadex®)
  • Raloxifene (Evista®)

Antiandrogens

  • Spironolactone (Aldactone®)
  • Finasteride (Proscar®, Propecia®)

Bone & Mineral Metabolism

Anti-Resorptive Agents

Bisphosphonates

Oral:

IV:

RANKL Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Calcitonin

Anabolic / Bone-Forming Agents

Vitamin D & Calcium Axis

Vitamin D & Analogs

Nutritional:

Active Forms:

Calcium Supplements

Hyperparathyroidism / CKD-MBD

Calcimimetics

Phosphate Binders

Calcium-based:

Non-calcium:

FGF23 Pathway

Clinical Groupings

Osteoporosis:

  • Bisphosphonates
  • Denosumab
  • Teriparatide / Abaloparatide
  • Romosozumab
  • Raloxifene

CKD–Mineral Bone Disease:

  • Vitamin D analogs
  • Calcimimetics
  • Phosphate binders

Hypercalcemia:

  • IV Bisphosphonates
  • Denosumab
  • Calcitonin

Paget Disease:

  • Bisphosphonates

Related:

endocrine/start.1770991770.txt.gz · Last modified: by andrew2393cns